Related Experiment Videos
Multiple myeloma: relationship between survival and cellular morphology.
P Pasqualetti1, R Casale, A Collacciani
1Department of Internal Medicine, School of Medicine and Surgery, University of L'Aquila, Italy.
American Journal of Hematology
|February 1, 1990
Summary
A new Multiple Myeloma Cellular Score (MMCS) was developed using myeloma cell morphology. This score significantly predicts survival in multiple myeloma patients, aiding in staging and prognosis.
Area of Science:
- Hematology
- Oncology
- Biostatistics
Background:
- Multiple myeloma is a hematologic malignancy characterized by the proliferation of plasma cells in the bone marrow.
- Accurate prognostic markers are crucial for effective patient management and treatment stratification in multiple myeloma.
Purpose of the Study:
- To develop and validate a novel cellular scoring system for multiple myeloma based on morphological cell categorization.
- To assess the prognostic value of the Multiple Myeloma Cellular Score (MMCS) in predicting patient survival.
Main Methods:
- Morphological evaluation of myeloma cells in bone marrow aspirates from 121 newly diagnosed multiple myeloma patients.
- Application of Cox's proportional hazards model to determine coefficients for total myeloma cells and plasmablasts.
- Calculation of the Multiple Myeloma Cellular Score (MMCS) using derived coefficients.
Main Results:
- The MMCS effectively stratified patients into three distinct prognostic stages.
- Significant differences were observed in mean survival times (P < .001) and survival curves (P < .00001) across MMCS stages.
- A strong correlation (P < .00001) was established between the MMCS and overall patient survival.
Conclusions:
- The Multiple Myeloma Cellular Score (MMCS) is a significant and reliable prognostic tool for multiple myeloma.
- MMCS provides valuable insights into patient survival, facilitating improved clinical decision-making and patient counseling.